EUVIMEDEUVIMED entdecken
Open Access

Potent and Protease Resistant Azapeptide Agonists of the GLP‐1 and GIP Receptors

Tristan C Dinsmore iD, Jamie Liu iD, Jiayuan Miao iD, Özge Ünsal iD, Damla Sürmeli iD, Martin Beinborn iD, Yu-Shan Lin iD, Krishna Kumar iD

Angewandte Chemie International Edition · 02.12.2024 · 63 (49)

DOI: 10.1002/anie.202410237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 25.11.2024. Verfasst von Tristan C Dinsmore und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Tufts University, 02155, Medford, Massachusetts, USA. Hauptthemen laut MEDLINE: Receptors, Gastrointestinal Hormone, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Division of Diabetes, Endocrinology, and Metabolic Diseases, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut‐derived peptide hormones glucagon‐like peptide‐1 (GLP‐1) and glucose‐dependent insulinotropic polypeptide (GIP) play important physiological roles including glucose homeostasis and appetite suppression. Stabilized agonists of the GLP‐1 receptor (GLP‐1R) and dual agonists of GLP‐1R and GIP receptor (GIPR) for the management of type 2 diabetes and obesity have generated widespread enthusiasm and have become blockbuster drugs. These therapeutics are refractory to the action of dipeptidyl peptidase‐4 (DPP4), that catalyzes rapid removal of the two N‐terminal residues of the native peptides, in turn severely diminishing their activity profiles. Here we report that a single atom change from carbon to nitrogen in the backbone of the entire peptide makes them refractory to DPP4 action while still retaining full potency and efficacy at their respective receptors. This was accomplished by use of aza‐amino acids, that are bioisosteric replacements for α‐amino acids that perturb the structural backbone and local side chain conformations. Molecular dynamics simulations reveal that aza‐amino acid can populate the same conformational space that GLP‐1 adopts when bound to the GLP‐1R. The insertion of an aza‐amino acid at the second position from the N‐terminus in semaglutide and in a dual agonist of GLP‐1R and GIPR further demonstrates its capability as a viable alternative to current DPP4 resistance strategies while offering additional structural variation that may influence downstream signaling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Gastrointestinal HormoneGlucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide-1 Receptor AgonistsHumansDipeptidyl Peptidase 4PeptidesStructure-Activity RelationshipGlucagon-Like Peptide 1

Stichwörter der Autor:innen

AzapeptidesDual-agonistGIPGLP-1Protease resistant

Substanzen

Receptors, Gastrointestinal HormoneGlucagon-Like Peptide-1 Receptorgastric inhibitory polypeptide receptorDipeptidyl Peptidase 4PeptidesGlucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Chemistry, Tufts University, 02155, Medford, Massachusetts, USA.
  • Molecular Pharmacology Research Center, Tufts Medical Center, 02111, Boston, Massachusetts, USA.
  • Department of Biomedical Engineering, Tufts University, 02155, Medford, Massachusetts, USA.
  • Cancer Center, Tufts Medical Center, 02111, Boston, Massachusetts, USA.

ORCID-Profile: Tristan C Dinsmore, Jamie Liu, Jiayuan Miao, Özge Ünsal, Damla Sürmeli, Martin Beinborn, Yu-Shan Lin, Krishna Kumar

Förderung

  • NIGMS NIH HHS
  • Division of Diabetes, Endocrinology, and Metabolic Diseases
  • NIA NIH HHS
  • NIDDK NIH HHS
  • National Institute of General Medical Sciences
  • National Institute on Aging

Zitieren

APA

Dinsmore, T. C., Liu, J., Miao, J., Ünsal, Ö., Sürmeli, D., Beinborn, M., Lin, Y. S., & Kumar, K. (2024). Potent and Protease Resistant Azapeptide Agonists of the GLP‐1 and GIP Receptors. Angewandte Chemie International Edition, 63(49). https://doi.org/10.1002/anie.202410237

Vancouver

Dinsmore TC, Liu J, Miao J, Ünsal Ö, Sürmeli D, Beinborn M, et al. Potent and Protease Resistant Azapeptide Agonists of the GLP‐1 and GIP Receptors. Angewandte Chemie International Edition. 2024;63(49). doi:10.1002/anie.202410237

BibTeX
@article{Dinsmore2024,
  author = {Dinsmore, Tristan C and Liu, Jamie and Miao, Jiayuan and Ünsal, Özge and Sürmeli, Damla and Beinborn, Martin and Lin, Yu-Shan and Kumar, Krishna},
  title = {Potent and Protease Resistant Azapeptide Agonists of the GLP‐1 and GIP Receptors},
  journal = {Angewandte Chemie International Edition},
  year = {2024},
  volume = {63},
  number = {49},
  doi = {10.1002/anie.202410237}
}
Kostenlos starten →